TEMPE, Ariz. (Dec. 10, 2018) – Sonora Quest Laboratories, Arizona’s leading provider of diagnostic testing and information services, and Beacon Biomedical Inc., a Phoenix-based diagnostic laboratory focused on commercializing early detection cancer tests, have jointly announced the availability of Beacon’s new colorectal cancer screening blood test called BeScreened™-CRC. Under an exclusive partnership the test is now available directly to consumers without a doctor’s order through Sonora Quest’s My Lab ReQuest™, their self-ordered lab testing product which is available on-line and at all of Sonora Quest’s 70-plus patient service centers across Arizona. In the near future, Sonora Quest and Beacon Biomedical intend on offering BeScreened-CRC throughout their entire network, including primary healthcare providers.

Recognizing that many people are unable or unwilling to use existing screening tests, Beacon Biomedical developed BeScreened-CRC as a convenient alternative to enable early detection, improve healthcare outcomes and reduce costs. BeScreened-CRC is 94 percent accurate at detecting the likely presence or absence of colorectal cancer, even in its earliest stages. As a blood test, it has the potential to remove many of the barriers to screening due to the test’s simplicity and ease of adoption, and it can be collected at the same time as other blood tests with no special preparation needed.

Download the press release to read more!